Evogene (EVGN) Enterprise Value (2012 - 2026)

Evogene has disclosed Enterprise Value across 15 years of filings, most recently posting -$5.5 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 143.59% year-over-year to -$5.5 million; the TTM figure through Jun 2026 stood at -$5.5 million (down 143.59% YoY), while the FY2025 annual figure was $8.7 million, down 33.96% from the prior year.
• Enterprise Value came in at -$5.5 million for Q2 2026 at Evogene, up from -$6.3 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $40.7 million in Q2 2023 to a low of -$8.5 million in Q3 2025.
• Average Enterprise Value over 5 years is $10.3 million, with a median of $6.8 million recorded in 2022.
• Year-over-year, Enterprise Value jumped 7144.89% in 2023 and plunged 271.74% in 2026.
• Over 5 years, Enterprise Value stood at $387308.0 in 2022, then jumped by 7144.89% to $28.1 million in 2023, then plunged by 53.1% to $13.2 million in 2024, then slumped by 33.96% to $8.7 million in 2025, then tumbled by 163.05% to -$5.5 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were -$5.5 million in Q2 2026, -$6.3 million in Q1 2026, and $8.7 million in Q4 2025.